Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(4 sites)
United States
University of Miami Sylvester Comprehensive Cancer Center, Miami, Florida 33136, Miami, Florida Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, Indiana Albert Einstein Health Network, The Bronx, New York The University of Texas MD Anderson Cancer Center, Houston, Texas